STRATEC SE

Director's Dealing • Aug 15, 2011

News Details

Directors’ Dealings | 15 August 2011 20:45

DGAP-DD: STRATEC Biomedical AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Last name: Steidle First name: Bernd M. Position: Member of a managing body Information about the transaction with duty of notification Description of the financial instrument: STRATEC Biomedical AG / Ordinary Share ISIN/WKN of the financial instrument: DE0007289001 Type of transaction: Sale Date: 05.08.2011 Price: 30.15 Currency: EUR No. of items: 10000 Total amount traded: 301514.14 Place: Xetra Explanation for publication: Cashless exercise (exercising of stock options, including sale of shares by bank via Xetra marketplace; exercise price for underlying stock options: EUR 15.63 per stock option). The shares thereby sold result from stock options granted as a component of compensation. Sale as follows: date / average price / no of items / total amount traded — 08.04.2011 / EUR 30.22 / 3,692 / EUR 111,598.89 — 08.05.2011 / EUR 30.11 / 6,308 / EUR 189,915.25. Transaction closed. Information about the company with duty of publication Issuer: STRATEC Biomedical AG Gewerbestr. 37 75217 Birkenfeld Deutschland ISIN: DE0007289001 WKN: 728900 End of Directors’ Dealings Notification (c) DGAP 15.08.2011 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 13977